Skip to content

Fintech Asia News Feed

Discover more about the world of artificial intelligence, machine learning, and blockchain through our carefully curated news feed.

27Jun 26
clinical-trial-evaluates-generative-ai-support-tool-in-primary-care

Clinical trial evaluates generative AI support tool in primary care

A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making but did not significantly change short-term patient outcomes. The study, published today in Nature Medicine is one of the first randomized controlled trials worldwide to test whether generative

Read more
27Jun 26
orderful-launches-mosaic:-the-first-ai-powered-edi-product-that-eliminates-mapping

Orderful Launches Mosaic: The First AI-Powered EDI Product That Eliminates Mapping

Orderful, the modern EDI platform trusted by leading global supply chains, today announced the release of Mosaic, the industry’s first AI-powered EDI integration product that eliminates mapping entirely and enables companies to integrate in hours using clean, readable JSON. Mosaic is both a new flagship product line and the long-term modernization foundation for all Orderful

Read more
27Jun 26
machine-learning-enhanced-nano-qsar-and-multiscale-modeling-for-predictive-nanomedicine:-applications-in-herbal-therapeutics-and-neglected-tropical-diseases-–-discover-nano

Machine learning-enhanced nano-QSAR and multiscale modeling for predictive nanomedicine: applications in herbal therapeutics and neglected tropical diseases – Discover Nano

1 Introduction 1.1 Nanomedicine and the growing importance of predictive modeling Nanomedicine has undergone rapid expansion over the past two decades, driven by advances in engineering lipid nanoparticles (LNPs), polymeric nanocarriers, inorganic NPs, and hybrid nanosystems designed for targeted and controlled drug delivery [1]. LNPs have become central to nucleic acid therapeutics, particularly following their

Read more
26Jun 26
toward-personalized-dcis-care-with-multimodal-ai

Toward Personalized DCIS Care With Multimodal AI

Zhou Ductal carcinoma in situ (DCIS) is early-stage, non-invasive breast cancer that has variable potential for invasive progression. Approximately 20% of patients with biopsy-proven DCIS are found only on surgical pathology to have invasive breast cancer occult to current clinical, imaging and pathologic methods of preoperative assessment. Current practice is to treat all DCIS cases

Read more

Get in touch

Follow us too!

HONG KONG  BANGKOK  |  JAKARTA

Back To Top